Align Technology | ALGN - Cost Of Sales

Stock Price
158.78
Daily Change
1.53 0.97%
Monthly
-17.16%
Yearly
-14.10%
Q2 Forecast
154.09

Align Technology reported $303.5M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
3M USD 3.57B 501M Mar/2026
Align Technology USD 303.5M 60.47M Mar/2026
Becton, Dickinson and Co. USD 2.56B 281M Mar/2026
Bruker USD 443.6M 84.4M Mar/2026
Cardinal Health USD 58.54B 4.82B Mar/2026
Charles River Laboratories USD 716.51M 5.76M Mar/2026
Cooper Companies USD 376.8M 87.4M Dec/2025
CVS Health USD 84.8B 7.32B Mar/2026
Danaher USD 2.36B 512M Mar/2026
Dentsply International USD 453M 65M Mar/2026
Dexcom USD 441.6M 25.3M Mar/2026
Henry Schein USD 2.3B 145M Mar/2026
Idexx Laboratories USD 418.08M 14.38M Mar/2026
Insulet USD 232.7M 17.5M Mar/2026
Integra LifeSciences USD 178.71M 14.73M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Masimo USD 152.8M 12.4M Mar/2026
McKesson USD 92.25B 10.22B Mar/2026
Mettler Toledo International USD 410.92M 63.05M Mar/2026
Revvity USD 323.46M 26.93M Mar/2026
Solventum Corp USD 911M 60M Mar/2026
Stryker USD 2.36B 325M Mar/2026
Teleflex USD 240.84M 20.7M Mar/2026
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
Veeva Systems USD 213.48M 14.01M Dec/2025
Waters USD 725M 350.06M Mar/2026
Zimmer Biomet Holdings USD 738.3M 231.8M Mar/2026
Zoetis USD 672M 71M Mar/2026